Care pathways in atopic dermatitis: a retrospective population-based cohort study.
Laura von KobyletzkiNatalia BallardiniDan HenrohnM P NearyGustaf OrtsäterKirk GealeGustaf OrtsäterIngrid Lindberg-SchagerA De GeerP NeregårdA ChaJoseph Christopher CappelleriW RomeroJacob Pontoppidan ThyssenPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
We found that healthcare contacts and use of AD-indicated treatments were concentrated in the year during which managed AD care was initiated and decreased significantly thereafter. Since a significant proportion of patients with AD have flares and persistent AD, our results suggest that patients with AD may be monitored infrequently and are undertreated. There is a need to inform practitioners about adequate treatment options to provide individualized care, in particular for patients with persistent severe AD.